concept of certain new etiologic forces which lie back of those which were once thought to be basic such as, for instance, the factors which lie back of the pneumococcus as a cause of pneumonia. Of late years conservative opinion does not allow anything to be really considered as 'etiology' unless we can succeed in getting it into a test tube, unless we can precipitate it, -unless we can crystallize it as it were. This is due, of course, to our current methodology which has, perhaps, become more of a religion than most of us realize. I think it may have led to a slightly narrow interpretation of clinical investigation on our part, for clinical investigation certainly should be given the opportunity to spread itself up into philosophy, if it will, as well as down into the basic sciences."
In the twenty-three years since these words were written, progress has been made; with considerable struggle, epidemiology is coming into its own as a basic and a clinical science, and its potentialities, forseen so clearly by Dr. Paul, are gradually being realized. During these years, he has been in the thick of the battle as an investigator and teacher, organizing and carrying out both frontal and flank attacks on various epidemiological problems at home and abroad. A year and a half ago, he had occasion to dictate an informal history of research in the Section of Preventive Medicine, with some notes on earlier work carried out while he was assistant and associate professor of Medicine. The transcription of this dictation he has never seen. Nevertheless, we are taking the liberty of presenting it here, without his knowledge (and with only minor editing) as a personal record of the pleasures of scientific exploration and discovery in the mid-20th century by a physician, a clinical epidemiologist, a naturalist, and a philosopher,-viz. J.R.P. DOROTHY M. HORSTMANN (Guest Editor).
FROM THE NOTEBOOK OF JOHN RODMAN PAUL
"At an earlier date, some four or five months ago, I dictated an outline of the activities of the Department of Medicine during the 1920's and '30's with emphasis upon the work of Blake and Trask on scarlet fever, their recognition of the scarlatinal toxin, and the use of antisera in the therapy of the disease. This was at a time when scarlet fever was a much more serious disease than it is at present. The report also emphasized Dr. Blake's work on pneumococcal pneumonia, his discovery and classification of pneumococcus variance, and later a great deal of work on the therapy of pneumonia, both by pneumothorax and later by chemotherapy and antibiotics.
From the work on scarlet fever, a disease of streptococcal origin, a number of lines of research developed. One of them included the studies on the epidemiology of rheumatic fever, which began before the role of the hemolytic streptococcus was appreciated. These studies utilized the family approach. On the basis of the way rheumatic fever spread through families, it was concluded that respiratory infection of some kind precipitated the acute attack of the disease. Rheumatic fever studies covered a period of at least eight years. During this time many of the environmental and social aspects were explored through intimate, long term studies on all members of 122 rheumatic families, and suitable control families. Some sixteen years later in 1947 many of the families were re-studied by Dr. Freida Gray and Dr. Robert Quinn.
DISCOVERY OF THE HETEROPHILE ANTIBODY TEST FOR THE DIAGNOSIS OF INFECTIOUS MONONUCLEOSIS
The events which led to the discovery of this diagnostic test may be of some interest. In 1929, Davidson of Chicago published a paper indicating that agglutinins to sheep cells were present in cases of serum sickness and he elaborated on the fact that this was an example of the Forssman antigen which had been demonstrated in 1911. It had been found that cells obtained from the organs of many animals when injected into an appropriate animal, such as a rabbit, were capable of giving rise not only to specific antibodies but also to nonspecific antibodies and these were demonstrable in varying degree in the form of hemolysins and agglutinins for sheep cells. Serum sickness was a very common disease in the New Haven Hospital during the period between 1928 and 1930, the widespread use of serum for cases of scarlet fever and for pneumonia providing plenty of clinical material. Davidson's results were quickly confirmed at the Yale Laboratory. At the same time, a study on rheumatic fever was going on, and the question arose as to whether the similarity of symptoms between rheumatic fever and serum sickness might not make it worthwhile to look for this heterophile antibody in cases of rheumatic fever. Such a search was started but we were unable to demonstrate a consistent or appreciable increase in the heterophile antibody content of the serum of patients suffering from rheumatic fever.
In the course of this study however, a number of controls from individuals suffering from serum sickness and a variety of other clinical conditions were assembled. Quite by accident it was discovered that antibodies capable of agglutinating sheep cells were present in the specimen of serum of a patient ill with infectious mononucleosis. The titer of antibody in this serum was much higher than had been described in serum disease or in any other clinical condition which we had studied. The man who was collecting the specimens of serum from the "control" patients was Dr. W. W. Bunnell, now a well-known practitioner of medicine in Farmington, Connecticut, and the patient on whom this discovery was made was a medical student, Mr. Franklin Foote, now a physician, and Commissioner of Health of the State of Connecticut. The finding seemed to be unusual and something of a fluke. It was not until a good seven or eight months later that another case of infectious mononucleosis came to our attention; this time also it was a medical student with infectious mononucleosis and jaundice and here again a high heterophile antibody titer was demonstrable. Gradually a series of infectious mononucleosis cases was assembled and it seemed that this was a fairly characteristic finding. The first paper, "The Presence of Heterophile Antibodies in Infectious Mononucleosis," was published in 1932, and covered a series of some 275 general hospital patients in which the test had been carried out, mostly with negative results, with the striking exception of the positive findings in the cases of infectious mononucleosis. That the test would be useful in diagnosis was established essentially by Dr. Bunnell, who in the subsequent year gathered a much larger series of cases. In view of the simplicity of the test it was not long before reports began to appear from many laboratories and almost immediately it was pointed out that the type of antibodies present in infectious mononucleosis differed from those present in serum disease, and the two could be differentiated by absorbing the serum with ox cells or guinea pig kidney. Some But to return to the interests of the Yale Laboratory in the 1930's: it was at this time that the Study Unit set for itself the task of determining whether there was more than one strain of poliomyelitis virus in the United States. A pioneer paper on this subject had already been published in 1931 by Burnet (later Sir Macfarlane) and McNamara from Australia. This paper had been received in the United States with some incredulity and the feeling that there was no telling what kind of poliovirus there might be in such far off places as Australia, but "it can't happen here." One of the most significant papers ever published by members of the Yale Poliomyelitis Study Unit was that designated as number 9 on its list. It appeared in 1933 and clearly described the immunological difference between two strains, as demonstrated by cross-immunization reactions and testing the resistance of monkeys by challenge with homologous and heterologous viruses. This work was carried forward for at least three years and by 1937 it was felt that one could divide the poliomyelitis virus family into at least two and possibly three types. In retrospect, whether we actually had a Type III poliovirus in our collection of strains is not absolutely clear. In any event, the work led in the not too distant future to the recognition that the poliovirus family consists of three members.
In the course of these experiments a number of monkeys which had been supposed to be immunized by inoculating them intracutaneously with formalinized virus, actually developed paralysis. The experimental use of formalinized vaccines as a method of immunizing monkeys brings up the inevitable question as to whether their use in man was contemplated at this early date by the Yale Poliomyelitis Study Unit. The answer is that in the mid-1930's this was a dominant theme in poliomyelitis research and immunization with formalin killed virus was being tried by Dr. Kolmer in Philadelphia and by Dr. Brodie of New York. Their work was unsuccessful, however, and the occurrence of possible vaccine induced cases gave a black eye to the idea of a killed poliovirus vaccine. Had the Unit worked on the subject then, it is probable that much time and effort might have been wasted because the separation of the family of polioviruses into different strains was very crude indeed. Furthermore, at the time infected monkey spinal cord was the only source of virus antigen; the development of a practical vaccine had to await the dawn of the tissue culture era fifteen years later.
The next item of considerable interest was the project undertaken in 1935 by members of the Unit who collected from the literature all examples of studies on serum antibodies in normal inhabitants in different parts of the world. This was the first study on serological epidemiology of any import, and the results, to our surprise, indicated that the highest rates of poliovirus antibodies occurred in tropical areas where the disease was supposed not to occur. At that time this seemed a paradoxical and unorthodox finding.
In 1937 the Unit was successful in isolating poliovirus from the feces of a child in the New Haven Hospital. Isolation of poliovirus from feces had been achieved once before by a Swedish group headed by Dr. Kling of Stockholm, but their experiments had been challenged by Dr. Flexner. Since 1932 the Yale Poliomyelitis Study Unit had attempted to repeat the work of Dr. Kling and his colleagues but the route of inoculation at that time, that is, into the brain of the monkey, was hazardous because of frequent bacterial contamination and brain abscesses, and no positive results were achieved. Besides, monkeys were limited in quantity and so expensive that it seemed wasteful to pursue this approach. The discovery which led subsequently to widespread use of fecal material in the study of the epidemiology of poliomyelitis came by pure chance. We happened to have a pet monkey in the laboratory named Bosco who was quite a beautiful animal of African origin, a Cercopithecus monkey which we had been conserving for no good scientific purpose at the cost of $1.00 per month. And yet no one had had the heart to use him on an experiment which might cause paralysis or early demise. In October, 1937 a poliomyelitis patient named Skolnick was admitted to the Pediatric Service of the New Haven Hospital and Dr. Alfred Vignec of that service, and Dr. Paul went to the home of this patient where an infant sibling was found to have fever but seemed otherwise normal. Throat washings and a stool specimen, whicb was conveniently produced at the time of the visit, were collected. It was at the suggestion of Dr. Vignec (now a well-known pediatrician of New York City) that the extract of fecal material from the Skolnick infant was inoculated intraperitoneally into Bosco. Both Dr. Trask and Dr. Paul, and last but not least, the faithful animal caretaker* who was devoted to Bosco, firmly believed that he would safely survive this procedure. But Bosco was paralyzed in all four limbs within a few days of inoculation and, sad as his death was, it opened up a large new field, quickly exploited by the Poliomyelitis Study Unit, even though the idea of isolating a virus from feces had very little appeal at that time to most good contemporary microbiologists. As for poliomyelitis, the accepted theory was that this was a disease in which the agent was spread by way of the respiratory tract. It soon became obvious that it was far easier to find poliovirus in the * Mr. Alfred Coppola, now working in the Department of Physiology in the same capacity. feces of patients ill or recently ill with poliomyelitis, than to find the virus in their nasopharyngeal washings, the customary source of virus isolation from living patients. Nevertheless, the devotees of the respiratory transmission theory of the virus still held out.
Following the detection of poliovirus in human feces and the use of stool isolations as an epidemiologic tool, it was a short step to see whether the virus could be demonstrated in sewage. This was soon found to be very easy. The first report on isolation of poliovirus from sewage came from the Yale Laboratory in 1939. Shortly after this a successful effort was made to determine the presence or survival of the virus in flies, particularly the filth flies whose favorite food is feces. These investigations, which came fast upon the heels of one another, gave the Yale Laboratory the reputation that it believed that poliomyelitis was a water-borne disease spread by sewage! It is true that the laboratory had stated early in 1939 that it was logical to regard poliomyelitis as an "intestinal disease" and this pronouncement had been greeted with some dismay on the part of our friends who felt that we had done good work up until then but had finally ''gone off the deep end." Actually the attitude which the laboratory soon took was that the presence of poliovirus in sewage provided a useful epidemiological tool, but there was no implication that the agent was spread by sewage. It was pointed out that sewage is full of pathogenic organisms including tubercle bacilli, but this does not mean that sewage is the usual vehicle of transfer of tubercle bacilli.
One of the uses to which the sewage findings were put was to test a theory largely promoted during the 1930's by Dr. Lloyd Aycock of the Harvard Infantile Paralysis Commission. The idea was that there was just as much poliomyelitis infection present in a community during the winter as in the summer, but there was a seasonal lack of resistance on the part of the human host which made him succumb to paralytic poliomyelitis in the summer. This lack of resistance was given the name "autarcesis" and it was produced somehow or other supposedly by hot weather. The discussions about this went on pro and con between Harvard and Yale for several years. It is possible that there was something in Dr. Aycock's argument, but in any event to prove or disprove his theory we went to great lengths. We sampled the sewage of a particular district in New York City each month over a period of six years in order to find out whether poliomyelitis virus was present there regularly month in, month out, during non-epidemic times, as well as during epidemics, as Aycock had predicted. Our findings indicated that poliomyelitis virus, detected by the cumbersome method of monkey inoculation then in use, was present in the raw sewage of New York City only during the summer and fall and most frequently when there were actual cases of poliomyelitis being reported there.
The presence of poliomyelitis virus in flies is another story. The actual role which they play in the dissemination of the disease has never been established but it seems very probable that in areas that are teeming with flies such as Cairo, Egypt, they do play a role. This evidence is supported by the experiments carried out in the Yale Laboratory in 1943 by Ward, Melnick, and Horstmann, who found that flies in an epidemic area can contaminate food with poliovirus, and when such contaminated food was fed to chimpanzees, poliovirus infection was induced in them. This indicated that flies could at least be mechanical carriers of the virus of poliomyelitis. Arguments as to how important flies are in the usual spread of the disease have been pursued for twenty years without reaching final conclusions. Two projects have been carried out in this laboratory over the years, the first one by Dr. Melnick and others, and a more recent one by Dr. Margret Gudnadottir, a fellow from Iceland. The work indicated that flies can maintain the virus for a period of two weeks, and Dr. Gudnadottir's findings suggest that slight multiplication does take place in the body of the fly. However, there is no evidence that flies play an essential role in the transmission of the virus in the manner in which mosquitoes are essential in the transmission of yellow fever or malaria.
The story of the work of the Yale Poliomyelitis Study Unit would be incomplete without emphasis upon the field work carried out during the 1930's. It is difficult today for us to realize how helpless physicians and health officers were in this period in the face of a severe poliomyelitis epidemic. Having issued proclamations in the newspaper, and quarantined the exposed households, there was little else they could do. However, it became fashionable for the health officers to call in a team of epidemiologists or research workers. They did not expect much from these workers but the feeling was that the presence of consultants or of a team of experts might give the public the impression that at least something was being done. This launched the Yale laboratory on a series of clinical epidemiological studies which gave us an opportunity to see the disease first hand in various locations. At first it was our practice to spend a month to six weeks in each epidemic area; in several of these a laboratory was set up complete with facilities for housing monkeys and inoculating them on the spot. Later with the advent of airplane travel, a series of short visits were generally made. Epidemiological studies of various types were carried out starting in New Haven in 1931; Philadelphia in 1932; in Los Angeles in 1934; in Toronto, Canada in 1937; in Charleston, South Carolina in 1939, also in that same year in Detroit, Michigan, and Buffalo, New York; in 1940, in Indianapolis, Indiana and in Huntington, West Virginia; in 1941 Miami, Florida, Cordova, Alabama, and Winnipeg, Canada, to mention only a few of these expeditions. It is hard to imagine the excitement and the misguided publicity which attended the arrival of the research workers in an epidemic area in the 1930's. In the long run, however, the time and effort spent in these endeavors cannot be considered wasted. Occasionally there was bitterness on the part of local research workers, but more often these ventures spelled the beginning of fine pieces of collaboration.
In It was but a matter of a few weeks to determine that the central nervous system tissue sent to this country and examined first at the Rockefeller Institute contained poliomyelitis virus. This finding was one of the reasons that our Commission was sent over to North Africa to investigate the situation. On arrival in Cairo, the laboratory was set up in conjunction with the 38th U.S. General Hospital (the Jefferson Medical School Hospital), and work was commenced at once on the cases of suspected poliomyelitis in U.S. troops which began to come in some numbers. Medical officers of the U.S. Army, especially the neurological consultants, were very skeptical about the clinical diagnosis of these cases. The clinical picture did not conform to their ideas of adult poliomyelitis, but the repeated isolation of strains of poliovirus from such cases was eventually convincing. The virus isolation work was carried out in monkeys which had to be obtained locally. Some of the members of the Commission (J.R.P.) had to visit Ethiopia in order to trap their own animals and bring them back to the laboratory in Cairo.
It was in this setting that an important epidemiological idea began to come into being. It grew out of the observation that adult poliomyelitis could exist and even thrive among visitors (i.e. susceptible immigrants) in an area where only infantile paralysis had been previously recognized; where even that was thought to be very uncommon; and where adult poliomyelitis among the native inhabitants was unknown. This indicated that young men of military age coming from countries with high standards of hygiene in which epidemic twentieth century poliomyelitis was plentiful enough, -such young men were highly susceptible when introduced into regions where sanitary arrangements were about as primative as could be imagined. Thus on exposure to populations in which poliovirus infection was probably endemic, they became infected readily, and as a result poliomyelitis began to crop up in the soldiers from England and from the United States. It seemed that poliomyelitis had become a military disease during the generation which separated World War I from World War II. During this period, in many of the more "developed" parts of the world it had been noticed that the age at which the disease was occurring had been pushed up a decade or more. In other words, people were acquiring poliovirus infections later in life than they had before, and as a result many arrived at military age without having had the benefit of previous inapparent immunizing infections. This was but one of the many examples of the changing pattern of poliomyelitis which subsequently became evident.
During this early part of the 1940's the Yale laboratory continued to send out teams to carry on field work in epidemic areas. Notable among these expeditions were those to Hickory, North Carolina in 1944, to Western New York State in the same year; to Patterson, New Jersey, and to Rockford, Illinois in 1945.
By the end of the 1940's some very important discoveries had been made. Previously Dr. Charles Armstrong of the National Institutes of Health had indicated that one strain of type II poliovirus would infect mice, an enormous boon to laboratory workers. Later, working under the National Foundation for Infantile Paralysis, a team of investigators in several laboratories had separated the polomyelitis virus family quite definitely into a group of three, types I, II, and III. This brought considerable order out of great chaos. And finally, in 1948 came the monumental discovery by Drs. Enders, Weller, and Robbins that the virus of poliomyelitis could be grown in tissue culture. The importance of this was not fully appreciated at first, but it was one of the greatest milestones in the history of the disease.
During the latter half of the 1940's the Yale Poliomyelitis Study Unit busied itself in large measure with developing the concept that poliomyelitis was a disease in which the epidemiologic picture differed in different parts of the world. Further studies on the distribution in troops in World War II, particularly in Japan, brought forth some interesting findings indicating that the rate at which soldiers acquired the disease in the Philippines, China, Burma, and India was ten times greater than the rate at which the disease was acquired by troops of similar age who remained at home.
Very shortly after these observations were made, a dramatic example of the behavior of poliomyelitis in highly susceptible populations in the arctic occurred in the form of an epidemic among Canadian Eskimos in 1948-49. There, in the fall of 1948, the disease was first introduced into settlements along the west coast of Hudson Bay. It spread rapidly northward where the epidemic eventually involved almost twenty per cent of the entire population with paralytic disease. All age groups were attacked, the highest rates of paralysis occurring in adults, and the lowest in infants! Stimulated by this event, the Yale Poliomyelitis Study Unit (J.R.P.) made an expedition in 1949 to Point Barrow on the north coast of Alaska, where in connection with the Arctic Research Laboratory an attempt was made to see whether the non-immune character of the Eskimos living in that part of the world could be demonstrated by serological means. Available tests for carrying out a study in serological epidemiology at the time were crude but, nevertheless, the study did prove of considerable value. It was found that among the members of the Point Barrow community virtually none under the age of twenty possessed antibodies to type II poliovirus, whereas about seventy per cent above twenty years did possess such antibodies. The ages of persons with type I antibodies was 35 and over, and with type III, 45 and over. This was a pilot study in serological epidemiology and opened a whole new field. It appeared that from the determination of the pattern of antibody distribution on an age specific basis, it was possible to retrace the history of an infection in an area where little or no accurate vital statistics had ever existed.
As a quick corollary to the Alaskan study, the next expedition which the Study Unit organized (and J.R.P. carried out) was to a part of the world which was selected because it is as completely opposite to barren arctic wastes as could be imagined, namely to a crowded Egyptian village in the outskirts of Cairo. It was felt that if the population of Cairo was sufficiently immune so that no adults ever acquired clinical poliomyelitis, it should be possible to document this fact in their antibody patterns. Such was indeed found to be the case: by the time they reached 3 or 4 years of age virtually all Egyptian children had antibodies to the three types of poliovirus. As an important by-product of this study, an alert graduate student working in the Section of Preventive Medicine found that in some of the bloods which were being tested for antibody content there was a virus present, and this agent was quickly identified with the help of Dr. Melnick as West Nile Fever virus. This virus has subsequently been shown to be the cause of a great deal of mild febrile illness in Egypt and in Israel. Although it had been discovered ten years earlier in Central Africa, the agent had never before been found so far north in Africa, and its importance as a producer of illness had gone unappreciated for many years.
Credit for this discovery is due to Miss VoHammie Barnett who died a few months after making this remarkable observation. Subsequently, serological surveys were carried out by the Yale group in other populations. These included the populations on the island of Tahiti, in Morocco, North Africa, in North Carolina, and later in Guatemala, Central America. During this period there was a sudden increase in the use of the antibody survey as a method of determining the immune status of given populations throughout the world.
Also in the 1940's, came the discovery of the Coxsackie group of viruses by Dr. Gilbert Dalldorf and Miss Grace Sickles. Dr. Melnick immediately became interested in work with these agents. Together with Dr. Edward C. Curnen, strains were isolated from cases of aseptic meningitis. Subsequently, Dr. Melnick and his collaborators were in the forefront in classifying this large family of agents, characterizing their physical properties, and studying their pathology, serology, and epidemiology.
We come now to a new decade and a new era in the history of poliomyelitis, for the 1950's marked the beginning of the era of the development of active immunization. The advent of the tissue culture method and the discovery that poliovirus produces a cytopathogenic effect on tissue culture cells by which its presence can be detected, enormously facilitated research work in this field. It was possible not only to isolate poliovirus readily and demonstrate antibodies, but means were now available for preparing a vaccine. On this basis, the work of Dr. Salk began early in 1952 and progressed successfully to the production of the vaccine for general use in April 1955. We have been asked many times why the Yale Laboratory having had such a fine background and having begun work on this very subject in 1936, never really pursued it to a satisfactory conclusion. Actually, the first formalinized killed vaccine antigens were administered by the Yale Poliomyelitis Study Unit in 1931 when Dr. Trask and Dr. Paul both were inoculated with small doses of formalinized vaccine to see if they could boost their own antibodies and quantitatively demonstrate this in the clumsy neutralization test in monkeys. It was not, obviously, a successful procedure. Killed vaccines had a bad name in the mid and late 1930's and the antibody tests were so poor that a book was written discrediting them almost completely.
The next efforts of the Unit to immunize man were made in 1946. A rather unfortunate choice was made at this time in that heat killed mouse brain virus was selected as the antigen for a vaccine. The decision to use heat inactivation rather than formalin was based partly on our earlier immunization experiments in monkeys carried out from 1935 to 1938; in several instances the formalin had failed to kill the poliomyelitis virus and we felt insecure about its adequacy. Obviously, we did not know how to use it. Our first vaccination trial in man was an effort to boost antibodies by inoculating the heat killed antigen. This work was carried out in Miami, Florida in 1946 by Dr. Horstmann. The method of measuring antibody rises by intracerebral neutralization tests in mice left a good deal to be desired. The results were not particularly successful; had they been a little more promising, we would have pushed forward at that time with all possible speed.
During the period 1946-49 we continued experiments on the use of heat killed antigens which were used not only in attempting to develop a skin test, but in an effort to immunize man. The work was carried out at the Southbury Training School, Southbury, Connecticut. At first we used as antigen the YSK (type II poliovirus) propagated in cotton rats, and heat inactivated at 700 for thirty minutes. Eventually, it was found that by concentrating the antigen one hundred times by ulracentrifugation, and by reducing the heat of inactivation from 70°to 60°C. the antigenicity was improved. In fact three of fourteen individuals tested showed rises in antibody after inoculation of this preparation. Unfortunately heat causes deterioration of the antigen to a far greater degree than does formalin; if only the result had been a little better than 20%o we would have gone forward on this lead. At the same time we began to work with oral immunization with heat killed material and shortly thereafter Dr. Melnick began to work on the attenuation of poliovirus strains which might be used in a vaccine. In all these experiments the results were a little under the level which would have caused us to pursue them with greater vigor.
In 1951, Dr. Horstmann again began work on the question of viremia in poliomyelitis. This had been studied in 1943, but at that time virus had been isolated from the blood of only 1 of 111 patients with the disease, and the conclusion was reached that viremia was rare and unimportant in the pathogenesis of poliomyelitis. In 1951 and 1952, however, we found that orally infected monkeys and chimpanzees regularly had virus in the blood. However, viremia was detected only in the incubation period and not after signs of the disease appeared. In the summer of 1952 Dr. Horstmann and Dr. Robert McCollum demonstrated viremia in human infections, in blood specimens collected from family contacts of paralytic cases, from those with asymptomatic infections, and from children with the "minor illness", the study having been carried out during an epidemic in Ohio. At Since the establishment of the unit a series of more than 325 papers on poliomyelitis have been published and a review of these titles has fairly well covered the story of the disease during this thirty year period.
STUDIES ON VIRAL HEPATITIS
Yale's contribution to the study of the etiology of infectious hepatitis deserves some mention. One of the first tasks of the various commissions of the Army Epidemiological Board, of which Francis G. Blake was appointed president early in 1941, was to investigate the outbreak of hepatitis which occurred in the Army as a result of the use of yellow fever vaccine among troops in 1942. Until 1944-45 there was no appreciation of the fact that there are two forms of hepatitis, the so-called infectious hepatitis and serum hepatitis. Whether the difference between these two forms is due to their being caused by two completely distinct viruses or by two varieties of the same virus is still a moot point; but it is sufficient to state that there are differences between the agents, and their modes of transmission differ, however indistinguishable clinically the two diseases may be at times.
In 1942 most physicians in the United States, and for that matter in the greater part of the world, recognized an epidemic form of mild jaundice, distinct from Weil's disease. It was an ill-defined entity, however, rather uncommon, and felt to be probably different from the common sporadic disease known as catarrhal jaundice. The spirochetal jaundice of Weil's disease was recognized as a diffuse hepatitis, whereas catarrhal jaundice was considered to be an obstructive jaundice due to primary inflammation of the bile ducts, and quite different in its pathology, prognosis, and clinical picture. This view had been held for a long time despite the fact that there was good clinical and epidemiologic evidence in the literature to indicate that it was incorrect.
Dr. George Blumer of this School had been among the first in this country to uphold the idea that catarrhal jaundice was the sporadic form of infectious hepatitis. His views were published in the Journal of the American Medical Association in 1923, shortly after an epidemic had been described among Yale students by Dr. Ira Hiscock among others. However, Dr. Blumer's view had been anticipated in a report by Cockayne in England published in 1912, giving an historical review with the comprehensive title, "Catarrhal Jaundice, Sporadic and Epidemic, and Its Relation to Acute Yellow Atrophy of the Liver." Cockayne's views and also those of Blumer received very little attention for many years. Catarrhal jaundice, it was insisted, was a catarrh of the biliary tract in which mucus plugs played a role. So strong was this view that one school championed the idea that a rational, direct, and effective method of therapy was the removal of this plug of inspissated mucus "corking" up the ampulla of Vater, by the introduction of magnesium sulfate into the duodenum. The great pathologist Virchow had described this plug and accounts of its supposed importance had been carried through successive editions of many textbooks (including the influential Osler's text) for almost two generations. Eppenger in Vienna was the first to suggest that the pathogenesis of catarrhal jaundice was really associated with hepatocellular necrosis. His paper was published in 1922. Eight years later Eppenger's views were upheld by Dr. Aronld Rich who, after studying the records of 11,500 autopsies performed at the Johns Hopkins Hospital during 40 years, reported that there was not a single case among them in which the diagnosis of "catarrhal jaundice" could be regarded as accurate. Thus, it seems that the concept of the pathogenesis of the clinical entity known as catarrhal jaundice had gone beyond the facts.
Outbreaks of serum hepatitis on the other hand, dated back to about 1883, and were observed following vaccination for smallpox, the use of arsphenamine in the treatment of syphilis, of insulin in diabetic clinics and in other situations in which the parenteral administration of drugs was used. Outstanding in the history of serum hepatitis were the cases which occurred during World War II following vaccination against yellow fever. At this time the virus used in yellow fever vaccine was grown in tissue cultures containing human serum in the media. In spite of this information, however, the epidemic of serum hepatitis fell upon the unsuspecting American Army like the bombshells falling on Pearl Harbor. As a result, many investigators in this country took upon themselves the study of a comparison between epidemic hepatitis and serum hepatitis. There seemed to be a difference: -one had a long incubation period ranging from 60 to 150 days, the other a shorter one from 15 to 40 days.
A great advance in the study of infectious hepatitis took place when the disease was first produced experimentally in man. In 1942, Voegt, in Germany, reported the transmission of hepatitis to volunteers by feeding them duodenal fluid or blood obtained from patients in the acute phase of the disease. Unfortunately, published accounts of his experiments are quite inadequate. In 1944, MacCallum and Bradley in England, at the Jaundice Center of the British Medical Research Council, obtained some highly significant experimental results. Their report, in the form of a letter published in the Lancet on 12 August 1944, described success in transmitting viral hepatitis to arthritic patients. Various routes of transmission had been used and the infective material included feces given by mouth. Independently, members of the Neurotropic Virus Commission here at Yale working largely under the direction of Major W. Paul Havens were successful in producing the disease in volunteers of Civilian Public Service Units, composed of conscientious objectors who were quartered in New Haven. These men were fed fecal specimens obtained from soldiers in the Mediterranean area during the epidemic of 1943. The experiments were begun in June and July of 1944, and the patients were housed on the infectious disease wards of the New Haven Hospital. The first definite experimental cases occurred in July and a report of this work was presented at the first meeting of the Hepatitis Study Group, held at the Rockefeller Institute for Medical Research in New York on 12 July 1944. It was published in November 1944. It can be fairly stated that this represented the first published successful demonstration in the United States of the enteric-oral transmission of infectious hepatitis.
Other aspects of the disease which were investigated in New Haven included the determination of the times at which virus could be found in the blood and in feces, both before and after the onset of jaundice; and an excellent study of the blood picture. Cross protection studies in volunteers indicated a lack of cross immunity between serum and infectious hepatitis. From this work, and from studies carried out elsewhere, a differentiation between the two hepatitis viruses was established, and the present concept of the two diseases emerged."
